The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancerFEBBO, P. G; KANTOFF, P. W; PLATZ, E. A et al.Cancer research (Baltimore). 1999, Vol 59, Num 23, pp 5878-5881, issn 0008-5472Article

No Association Between a Polymorphic Variant of the IRS-I Gene and Prostate Cancer RiskFALL, K; STARK, J. R; MUCCI, L. A et al.The Prostate. 2008, Vol 68, Num 13, pp 1416-1420, issn 0270-4137, 5 p.Article

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostateTAY, M.-H; KAUFMAN, D. S; OH, W. K et al.Annals of oncology. 2004, Vol 15, Num 6, pp 974-978, issn 0923-7534, 5 p.Article